Secukinumab in patients with psoriatic arthritis and axial manifestations: results from the double-blind, randomised, phase 3 MAXIMISE trial

Baraliakos X., Gossec L., Pournara E., Jeka S., Varela AM., D’Angelo S., Schulz B., Rissler M., Nagar K., Perella C., COATES LC.

Type

Journal article

Journal

Annals of the rheumatic diseases

Publisher

BMJ Publishing Group

Publication Date

02/12/2020

Permalink